Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Recombinant human monoclonal IgG1 antibody for fibroblast growth factor 23

EU orphan designation number: EU/3/14/1351   
Active ingredient: Recombinant human monoclonal IgG1 antibody for fibroblast growth factor 23
Indication: Treatment of X-linked hypophosphataemia
Sponsor: Kyowa Kirin Limited
Galabank Business Park, Galashiels, TD1 1QH, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page
Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
17/10/2014 Orphan designation EMA/OD/133/14 (2014)7650 of 15/10/2014
03/08/2016 Transfer of orphan designation EMA/OD/133/14/T/01 (2016)5126 of 01/08/2016